Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

LLLT increases hair density and growth in AGA patients.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Men with untreated male pattern hair loss continue to lose hair over a 5-year period.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

L-Cysteine may have health benefits, but its effectiveness is still debated due to limited clinical trial data.

Broussonetia papyrifera extract helps hair growth by regulating specific proteins.

Platelet-rich Plasma (PRP) helps treat hair loss effectively, especially when prepared using the double-spin method.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Alcohol-free minoxidil is better for treating hair loss in Indian men.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Cannabinoids might help treat skin problems but more research is needed to be sure.

More oxygen isn't always better and can sometimes be worse.

Quercetin may help improve symptoms of polycystic ovary syndrome.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

New therapies for alopecia areata show potential but need more research.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Stem-cell therapy shows promise for skin conditions but needs more research.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.